ESC 365 - Combination of fenestrated atrial septal occluder with targeted medical therapy in patients with secundum atrial septal defect and severe pulmonary arterial hypertension

ESC Premium Access

Combination of fenestrated atrial septal occluder with targeted medical therapy in patients with secundum atrial septal defect and severe pulmonary arterial hypertension

Session: Drug therapy in congenital heart disease - What are the options and the needs?

Topic: Intervention

Speaker: Doctor C. Yan (Beijing, CN)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Chaowu Yan

Fuwai Hospital, CAMS and PUMC, Beijing (China)

0 follower

4 more presentations in this session

Thromboembolic prevention in adolescents and adults with Fontan circulation: Is ASS a therapeutical option in long-standing Fontan circulation?

Speaker: Assistant Professor M. Westhoff-Bleck (Hannover, DE)

Thromboembolism and bleeding in adults with congenital heart disease using non-vitamin K antagonist oral anticoagulants for thromboembolic prevention: a prospective worldwide observational study

Speaker: Miss H. Yang (Singapore, SG)

Drug therapy in adult congenital heart disease: the burden of polypharmacy

Speaker: Ms O. Woudstra (Amsterdam, NL)

Selective Heart Rate inhibition improves inadequate exercise response in Fontan Circulation

Speaker: Mr B. Ruijsink (London, GB)

Access the full session

Drug therapy in congenital heart disease - What are the options and the needs?

Speakers: Doctor C. Yan, Assistant Professor M. Westhoff-Bleck, Miss H. Yang, Ms O. Woudstra, Mr B. Ruijsink

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources